• Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Daebongls Co Ltd

+ Add to Watchlist

078140:KS

8,120 KRW 310 3.68%

As of 01:11:15 ET on 12/26/2014.

Snapshot for Daebongls Co Ltd (078140)

Open: 8,470 Day's Range: 8,120 - 8,550 Volume: 174,600
Previous Close: 8,430 52wk Range: 3,980 - 13,000 1-Yr Rtn: +95.92%

Stock Chart for 078140

No chart data available.
  • 078140:KS 8,120
  • 1D
  • 1M
  • 1Y
8,430
Interactive 078140 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 078140

Current P/E Ratio (ttm) 18.0444
Estimated P/E(12/2014) 14.1783
Relative P/E vs. KOSPI 0.6543
Earnings Per Share (KRW) (ttm) 450.0000
Est. EPS (KRW) (12/2014) 572.7050
Est. PEG Ratio -
Market Cap (M KRW) 90,023.02
Shares Outstanding (M) 11.09
30 Day Average Volume 147,990
Price/Book (mrq) 2.0601
Price/Sale (ttm) 2.0564
Dividend Indicated Gross Yield 0.62%
Cash Dividend (KRW) 50.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth 14.87%
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 078140

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 078140

DAEBONGLS Co., Ltd. manufactures various raw materials for pharmaceuticals, cold permanent, wave, cosmetics, and food additives. The Company's product includes cefaclor, thiomin-ns, silymarine, and erdostein. DAEBONGLS provides products for pharmaceutical and cosmetic manufacturing companies.

Park Jong-HoCo-CEO/Co-Rep DirectorPark Jin-HoCo-CEO/Co-Rep Director
Kim Yong-GilManaging Director
More Company Profile & Key Executives for 078140

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil